IT1109331B - Procedimento per la preparazione di 9-(omega-eteroarilammino-alchilammino)-eritromicine e loro sali prodotto ottenuto e composizioni medicinali che li contengono - Google Patents

Procedimento per la preparazione di 9-(omega-eteroarilammino-alchilammino)-eritromicine e loro sali prodotto ottenuto e composizioni medicinali che li contengono

Info

Publication number
IT1109331B
IT1109331B IT51850/78A IT5185078A IT1109331B IT 1109331 B IT1109331 B IT 1109331B IT 51850/78 A IT51850/78 A IT 51850/78A IT 5185078 A IT5185078 A IT 5185078A IT 1109331 B IT1109331 B IT 1109331B
Authority
IT
Italy
Prior art keywords
eteroarilamino
erythromycines
alchylamine
omega
procedure
Prior art date
Application number
IT51850/78A
Other languages
English (en)
Other versions
IT7851850A0 (it
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IT7851850A0 publication Critical patent/IT7851850A0/it
Application granted granted Critical
Publication of IT1109331B publication Critical patent/IT1109331B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IT51850/78A 1977-11-10 1978-11-09 Procedimento per la preparazione di 9-(omega-eteroarilammino-alchilammino)-eritromicine e loro sali prodotto ottenuto e composizioni medicinali che li contengono IT1109331B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772750288 DE2750288A1 (de) 1977-11-10 1977-11-10 Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
IT7851850A0 IT7851850A0 (it) 1978-11-09
IT1109331B true IT1109331B (it) 1985-12-16

Family

ID=6023435

Family Applications (1)

Application Number Title Priority Date Filing Date
IT51850/78A IT1109331B (it) 1977-11-10 1978-11-09 Procedimento per la preparazione di 9-(omega-eteroarilammino-alchilammino)-eritromicine e loro sali prodotto ottenuto e composizioni medicinali che li contengono

Country Status (18)

Country Link
US (1) US4256738A (it)
EP (1) EP0001981B1 (it)
JP (1) JPS5476588A (it)
AT (1) AT361623B (it)
AU (1) AU4144878A (it)
CA (1) CA1107726A (it)
DE (2) DE2750288A1 (it)
DK (1) DK499778A (it)
ES (1) ES474693A1 (it)
FI (1) FI783417A7 (it)
GR (1) GR65281B (it)
IL (1) IL55906A0 (it)
IT (1) IT1109331B (it)
NO (1) NO783767L (it)
NZ (1) NZ188872A (it)
PT (1) PT68771A (it)
YU (1) YU261178A (it)
ZA (1) ZA786313B (it)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US5739127A (en) * 1996-11-08 1998-04-14 Bayer Aktiengesellschaft 2,4'-bridged bis-2,4-diaminoquinazolines
WO2003001887A2 (en) * 2001-06-28 2003-01-09 Essential Therapeutics, Inc. Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
CN101163706A (zh) * 2005-04-21 2008-04-16 贝林格尔·英格海姆国际有限公司 用于治疗炎性疾病的二氢噻吩并嘧啶
AR059898A1 (es) * 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
KR20100065191A (ko) 2007-09-14 2010-06-15 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 １,３-이치환된 ４-(아릴-ｘ-페닐)-１ｈ-피리딘-２-온
AU2008297877C1 (en) * 2007-09-14 2013-11-07 Addex Pharma S.A. 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
DE602008004794D1 (de) * 2007-09-14 2011-03-10 Addex Pharmaceuticals Sa 1',3'-disubstituierte 4-phenyl-3,4,5,6-tetrahydro-2h,1'h-ä1,4'übipyridinyl-2'-one
RU2500681C2 (ru) * 2007-10-19 2013-12-10 Берингер Ингельхайм Интернациональ Гмбх Замещенные гетероциклом пиперазинодигидротиенопиримидины
US8486948B2 (en) 2007-10-19 2013-07-16 Boehringer Ingelheim International Gmbh Piperazinodihydrothienopyrimidine derivatives
EP2610258B1 (de) * 2007-10-19 2014-08-27 Boehringer Ingelheim International Gmbh Substituierte Piperidino-Dihydrothienopyrimidine
US8785486B2 (en) * 2007-11-14 2014-07-22 Janssen Pharmaceuticals, Inc. Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
EP2344470B1 (en) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CN102186477B (zh) 2008-10-16 2013-07-17 奥梅-杨森制药有限公司 作为代谢型谷氨酸受体调节剂的吲哚和苯并吗啉衍生物
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
AR076861A1 (es) 2009-05-12 2011-07-13 Addex Pharma Sa Derivados de 1,2,4-triazolo (4,3-a)piridina y su uso como moduladores alostericos positivos de los receptores de mglur2
WO2010130422A1 (en) 2009-05-12 2010-11-18 Ortho-Mcneil-Janssen Pharmaceuticals, Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CA2814998C (en) 2010-11-08 2019-10-29 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
ES2552455T3 (es) 2010-11-08 2015-11-30 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
JP2016531870A (ja) * 2013-09-27 2016-10-13 ニンバス アイリス， インコーポレイテッド Ｉｒａｋ阻害剤およびその使用
PH12019500127B1 (en) 2014-01-21 2022-05-04 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
SMT201900545T1 (it) 2014-01-21 2019-11-13 Janssen Pharmaceutica Nv Combinazioni comprendenti modulatori allosterici positivi o agonisti ortosterici del recettore glutammatergico metabotropico sottotipo 2 e loro utilizzo
CN106674132B (zh) * 2016-11-22 2019-04-26 上海书亚医药科技有限公司 一种嘧啶类除草剂的制备方法与应用
CN112569239B (zh) * 2020-12-18 2021-12-28 北京鑫开元医药科技有限公司 作为tlr8激动剂的药物组合物、其制备方法及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3650376A (en) * 1970-08-17 1972-03-21 Conveyor Systems Accumulating conveyor
GB1345524A (en) * 1970-09-30 1974-01-30 Lilly Industries Ltd N-heteroarylidene erythomycylamines
DE2515077A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue 9-alkylidenamino-erythromycine, ihre salze und verfahren zu ihrer herstellung
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf

Also Published As

Publication number Publication date
ATA773178A (de) 1980-08-15
NZ188872A (en) 1981-05-29
IL55906A0 (en) 1979-01-31
NO783767L (no) 1979-05-11
ZA786313B (en) 1980-07-30
EP0001981A1 (de) 1979-05-30
JPS5476588A (en) 1979-06-19
DE2860585D1 (en) 1981-04-23
GR65281B (en) 1980-08-01
AT361623B (de) 1981-03-25
EP0001981B1 (de) 1981-04-01
IT7851850A0 (it) 1978-11-09
DE2750288A1 (de) 1979-05-17
ES474693A1 (es) 1979-04-01
US4256738A (en) 1981-03-17
AU4144878A (en) 1979-05-17
DK499778A (da) 1979-05-11
CA1107726A (en) 1981-08-25
PT68771A (de) 1978-12-01
YU261178A (en) 1982-08-31
FI783417A7 (fi) 1979-05-11

Similar Documents

Publication Publication Date Title
IT1109331B (it) Procedimento per la preparazione di 9-(omega-eteroarilammino-alchilammino)-eritromicine e loro sali prodotto ottenuto e composizioni medicinali che li contengono
IT1109339B (it) Procedimento per la preparazione di derivati amminici e composizioni farmaceutiche che li contengono e prodotto ottenuto
IT1034961B (it) Procedimento per la preparazione di dialchilcarbonati
IT7850335A0 (it) Procedimento per la preparazione di naftiridinoni sostituiti e prodotto ottenuto
IT1058859B (it) Immino alchil immino fosfonati procedimento per la loro preparazione e modo di usarli
IT1113469B (it) Procedimento per la preparazione di 2-fenilimmino-imidazolidine sostituite e loro sali di addizione acida composizioni famaceutiche che li contengono e prodotto ottenuto
IT8049165A0 (it) Nuovi derivati di alfa-fenil 2-pirrolidinmetanolo e loro sali e procedimento per la loro preparazione
IT1069532B (it) Procedimento per la preparazione di sali fosfatici
IT7851284A0 (it) Procedimento per la produzione di tiopropionammidi e loro composizioni farmaceutiche
IT1196531B (it) Composti piperazinil-benzoeterociclici procedimento per produrli e preparato farmaceutico che li contiene
IT1129933B (it) Derivati tioetilammidici loro composizioni farmaceutiche e procedimento per la loro preparazione
IT8049209A0 (it) Composti ai-77 loro sali farmaceuti camente accettabili e procedimento per produrli
IT1114720B (it) Procedimento per la preparazione di derivati di 2-fenilimmino-imidazolidine composizioni farmaceutiche che li contengono e prodotto ottenuto
IT1111061B (it) Procedimento per la produzione di imidazobenzossazine e loro sali prodotto ottenuto e composizioni farmaceutiche che lo contengono come in grediente attivo
IT1193334B (it) Composti triazinonici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8047849A0 (it) Derivati di ossoimidazo chinossalina e loro sali, procedimento per laloro preparazione, loro impiego come medicamenti e composizioni farmaceutiche che li contengono
IT1109266B (it) Piperazine bisotituite procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1171361B (it) Amminociclopentanon-ammidi e procedimento per la loro preparazione e formulazione farmaceutica
IT8068555A0 (it) Derivati di 1 2 4 ossadiazolin 5 one procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT7949743A0 (it) Procedimento per la preparazione di derivati acetilenici di androst-4ene e composizioni farmaceutiche che li contengono e prodotto ottenuto
IT1148265B (it) Tetraidropiridin-4-il indolo e loro sali procedimento per la loro preparazione loro impiego come medicamenti e composizioni che li contengono
DE2862327D1 (en) Pentapeptide-n-alkylamides and their acid addition salts, methods for preparation of these compounds and pharmaceutical formulations containing them
IT1105064B (it) Alchil(inferiore)2-tri-alchil(inferiore)sililacetilen-n-carbossiglicinati e procedimento per il loro impiego per la preparazione di prodotti farmaceutici
IT1157750B (it) Procedimento per la preparazione di derivati di acido 1-idrocarbilpirrolo-2-acetico e prodotto ottenuto
IT1108036B (it) Tiobenzilpirimidine procedimento per la loro preparazione e prodotti farmaceutici contenenti tali composti